EMEA-000718-PIP01-09-M06
Key facts
| Invented name |
Adempas
|
| Active substance |
riociguat
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0289/2016
|
| PIP number |
EMEA-000718-PIP01-09-M06
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of pulmonary hypertension
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Bayer Pharma AG
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000718-PIP01-09-M06
|
| Compliance opinion date |
11/12/2020
|
| Compliance outcome |
positive
|